HIGHLIGHTS
- who: Li Jiang from the School of Medicine, University of Electronic Science and Technology of China, Chengdu, China have published the research: Safety and efficacy of paclitaxel plus carboplatin versus paclitaxel plus cisplatin in neoadjuvant chemoradiotherapy for patients with locally advanced esophageal carcinoma: a retrospective study, in the Journal: (JOURNAL)
- what: The aim of this study was to compare the safety of TP and TC regimens by comparing treatment-related AEs and the efficacy of TP and TC regimens, considering pathological complete remission (pCR) rate, radical resection rate (R0 resection rate), and 3-year overall . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.